Phase 1 trial: T4 immunotherapy of head and neck cancer

Stuart Hogarth

DNA patents beyond clinical genetics: HPV testing and cervical cancer screening in China, the UK and USA. A comparative investigation of the bioethics of biomarker IP and its implications for public p

Oesophagus Larynx Other pharynx Lip, oral cavity Nasopharynx

Amitabh Chak

Genetic Determinants of Barretts Esophagus and Esophageal Adenocarcinoma

Oesophagus

Pathology

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Nasopharynx Oesophagus

Norman Wolmark

NRG Oncology Network Group Operations Center

Nasopharynx Oesophagus

Radiation Oncology Surgery / Surgical oncology

Shahzadi Ayesha Noorani

Molecular Phenotyping as a novel method of lymph node tracking in oesophageal cancer

Oesophagus

Condeelis S John

Tumor microenvironments determing migration, dissemination and dormancy

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx Breast

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Lip, oral cavity Leukaemia

Pathology

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Surbhi Grover

A Study of Prevalence of HPV and Determinants of Poor Outcomes of HIV Positive and Negative Patients with Oropharyngeal Cancers in Botswana

Other pharynx Lip, oral cavity

Pathology